Is Enliven Therapeutics, Inc. (ELVN) a Buy, Sell, or Hold?
Enliven Therapeutics, Inc.
NASDAQ:ELVN
$51.73 USD
$0.86 (1.69%)
- Volume
- 749.92K
- Average Volume
- 1.33M
- Market Capitalization
- $3.7B
- P/E Ratio
- -31.54
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $52.39
- Year Low
- $14.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $40.32
ELVN Dividend History by Quarter
| Announced | Period | Amount | Ex-Dividend Date | Record Date | Payable Date |
|---|